Dr Richard Tothill BSc (Hons) PhD is a group leader and head of the Rare Disease Oncogenomics (RADIO) Laboratory within Department of Clinical Pathology and the Centre for Cancer Research at the University of Melbourne.
Dr Tothill received his PhD from the University of Melbourne in 2005 within the laboratory of Professor David Bowtell. Preceding this, he was a research scientist working within the pharmaceutical industry (1998-2000, Glaxo-Welcome Genetics Division, UK). Since 2001 he has established a career in the field of cancer genomics. His work has been highly translational with a heavy focus on the development and adoption of breakthrough genomic technologies.
Dr Tothill’s highly cited research has included development and application of diagnostic methods for cancers of unknown primary involving gene-expression profiling and high-throughput DNA sequencing. Other research has included the genomic analysis of ovarian cancer and more recently rare neuroendocrine tumours (NETs) including Merkel cell carcinoma, phaeochromocytoma/paraganglioma and pancreatic NETs.